Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithra J Mandrekar

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Dose-finding trial designs for combination therapies in oncologySumithra J Mandrekar
Clinical Trials (London, England)|December 2, 2016
Daniel J. Sargent, 1970-2016Sumithra J Mandrekar
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Early phase trial designs and endpoints for targeted therapies in rare genotype subsetsSumithra J Mandrekar
NEJM Evidence|February 6, 2024
High-Dose Glucocorticoids for Treating Sudden Hearing Loss: Cart before the Horse?Jun Yin, Sumithra J Mandrekar
Chinese Clinical Oncology|November 22, 2014
Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicineSumithra J Mandrekar, Daniel J Sargent
Statistical Methods in Medical Research|December 5, 2003
Are our data symmetric?Sumithra J Mandrekar, Jayawant N Mandrekar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 18, 2011
Systematic reviews and meta-analysis of published studies: an overview and best practicesJayawant N Mandrekar, Sumithra J Mandrekar
Journal of Biopharmaceutical Statistics|September 7, 2017
Definitions and statistical properties of master protocols for personalized medicine in oncologyLindsay A Renfro, Sumithra J Mandrekar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Randomized phase II trials: time for a new era in clinical trial designSumithra J Mandrekar, Daniel J Sargent
Annals of Translational Medicine|November 22, 2016
Time to progression ratio: promising new metric or just another metric?Ming-Wen An, Sumithra J Mandrekar
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Dose-finding trial designs for combination therapies in oncologySumithra J Mandrekar
Clinical Trials (London, England)|December 2, 2016
Daniel J. Sargent, 1970-2016Sumithra J Mandrekar
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Early phase trial designs and endpoints for targeted therapies in rare genotype subsetsSumithra J Mandrekar
NEJM Evidence|February 6, 2024
High-Dose Glucocorticoids for Treating Sudden Hearing Loss: Cart before the Horse?Jun Yin, Sumithra J Mandrekar
Chinese Clinical Oncology|November 22, 2014
Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicineSumithra J Mandrekar, Daniel J Sargent
Statistical Methods in Medical Research|December 5, 2003
Are our data symmetric?Sumithra J Mandrekar, Jayawant N Mandrekar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 18, 2011
Systematic reviews and meta-analysis of published studies: an overview and best practicesJayawant N Mandrekar, Sumithra J Mandrekar
Journal of Biopharmaceutical Statistics|September 7, 2017
Definitions and statistical properties of master protocols for personalized medicine in oncologyLindsay A Renfro, Sumithra J Mandrekar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Randomized phase II trials: time for a new era in clinical trial designSumithra J Mandrekar, Daniel J Sargent
Annals of Translational Medicine|November 22, 2016
Time to progression ratio: promising new metric or just another metric?Ming-Wen An, Sumithra J Mandrekar
Pageof 16